The prevalence of diagnosed disorders from recurrent use of sedative, hypnotic and anti-anxiety medications in adolescents and young adults has increased sharply since 2001, according to researchers.

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...